Results 51 to 60 of about 94,588 (272)

Recurrent fungal endophthalmitis after intravitreal injections of bevacizumab

American Journal of Ophthalmology Case Reports, 2020
Purpose: We intend to describe an uncommon case of recurrent post-cataract fungal endophthalmitis after intravitreal injections of Bevacizumab. Observations: A 73-year-old male, who underwent an uncomplicated cataract surgery 8 months ago, presented to ...
Alaa Din Abdin, Shady Suffo, Dina Alnaggar, Loay Daas, Berthold Seitz   +4 more
doaj   +1 more source

Improvement of Diabetic Macular Edema in the Fellow Eye After Monocular Intravitreal Bevacizumab Injection [PDF]

Hospital Practices and Research, 2017
Introduction: Because of bilateral involvement in many cases with diabetic macular edema, Intravitreal bevacizumab injection perform in both eyes. There are some reports of therapeutic effects in the fellow eye after monocular injection of anti-vascular ...
Hamidreza Torabi
doaj   +1 more source

Mortality in patients treated with intravitreal bevacizumab for age-related macular degeneration

BMC Ophthalmology, 2017
BackgroundThe aim of this study is to analyze mortality in patients treated with bevacizumab for wet AMD.MethodsWe conducted a retrospective case-control study between patients who received intravitreal injections of bevacizumab as the sole treatment for
J. Hanhart, D. Comaneshter, Y. Freier Dror, S. Vinker   +3 more
semanticscholar   +1 more source

Effectiveness of aflibercept in treating bevacizumab resistant macular edema [PDF]

Basrah Journal of Surgery
Aim Method Prospective study on patients with macular edema secondary to diabetes mellitus, retinal vein occlusion or wet AMD. All the patients enrolled in the study had partial or no response to bevacizumab represented by mild or no improvement
Hussain Khudair Yassin
doaj   +1 more source

Intravitreal Bevacizumab and Panretinal Photocoagulation for Proliferative Diabetic Retinopathy Associated with Vitreous Hemorrhage

, 2011
Purpose: To evaluate the efficacy of intravitreal bevacizumab with panretinal photocoagulation (PRP) in the treatment of proliferate diabetic retinopathy (PDR) with vitreous hemorrhage (VH).
黃昱勳;葉伯廷;陳慕師;楊長豪;楊中美, HUANG, YU-HSUN;YEH, PO-TING;CHEN, MUH-SHY;YANG, CHANG-HAO;YANG, CHUNG-MAY   +1 more
core   +1 more source

Outcomes of Abrupt Switch to Bevacizumab of Patients Undergoing Aflibercept Intravitreal Injections for Neovascular Age-Related Macular Degeneration in a Tertiary Center in Lombardy, Italy: A Real-Life Retrospective Analysis

Journal of Ophthalmology, 2021
Purpose. To assess real-life anatomical and functional outcomes of switch to bevacizumab in patients undergoing aflibercept intravitreal injections for nAMD. Methods.
Alessandro Randazzo, Raffaele Raimondi, Giovanni Fossati, Mary Romano, Tania Sorrentino, Carlo Castellani, Costanza Rossi, Giuseppe Cancian, Paolo Vinciguerra   +8 more
doaj   +1 more source

Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion

JAMA ophthalmology, 2019
This randomized clinical trial compares the clinical effectiveness of intravitreal therapy with ranibizumab vs aflibercept vs bevacizumab for the management of macular edema secondary to central retinal vein occlusion.
P. Hykin, A. T. Prevost, Joana C Vasconcelos, C. Murphy, J. Kelly, J. Ramu, B. Hounsome, Yit C. Yang, S. Harding, A. Lotery, U. Chakravarthy, S. Sivaprasad   +11 more
semanticscholar   +1 more source

Multi‐site performance of the telemedicine retinopathy of prematurity severity score (tROP‐SS)

Acta Ophthalmologica, EarlyView.
Abstract Objective This study aims to evaluate the performance of the telemedicine retinopathy of prematurity severity score (tROP‐SS) across all 14 NICUs in the TELEROP cohort against the modified ROP activity score (mROP‐ActS). Design Retrospective cohort study. Subjects The study included 2037 neonates who underwent ROP screening in 14 NICUs via the
Sarthak V. Shah, Arthur R. Brant, Cindy Zhao, Edward H. Wood, Shannon D. Scarboro, Jochen Kumm, Darius M. Moshfeghi   +6 more
wiley   +1 more source

The impact of systemic long‐term medications for the development of age‐related macular degeneration

Acta Ophthalmologica, EarlyView.
Abstract Purpose Age‐related macular degeneration (AMD) is a leading cause of central vision loss in the elderly; however, the systemic factors that modulate its incidence and progression remain unclear. We sought to determine whether long‐term use of systemic medications, including diabetes and antithrombotic medications, corticosteroids and ...
Hanna Heloterä, Reijo Sund, Toni Rikkonen, Kai Kaarniranta   +3 more
wiley   +1 more source

Structural and functional measures of efficacy in response to bevacizumab monotherapy in diabetic macular oedema: exploratory analyses of the BOLT study (report 4). [PDF]

PLoS ONE, 2013
BACKGROUND: To describe structural and functional changes associated with diabetic macular oedema (DMO) treated with intravitreal bevacizumab over 24 months.
Sobha Sivaprasad, Roxanne Crosby-Nwaobi, Simona Degli Esposti, Tunde Peto, Ranjan Rajendram, Michel Michaelides, Philip Hykin   +6 more
doaj   +1 more source